Acadia Pharmaceuticals is a healthcare company that develops and commercializes therapies for central nervous system disorders. They have been in the industry for over 25 years and are focused on developing solutions for dementia-related psychosis, negative symptoms of schizophrenia, Rett syndrome, and pain management. The company has warned candidates of fraudulent recruiting activity and advises them to verify the authenticity of any communication before responding.